110 related articles for article (PubMed ID: 26434826)
1. Clinicopathology Profile and Bone Involvement of Multiple Myeloma Patients in Dharmais National Cancer Hospital, Indonesia.
Sutandyo N; Firna E; Agustina J; Prayogo N; Widjaja L
Asian Pac J Cancer Prev; 2015; 16(15):6261-5. PubMed ID: 26434826
[TBL] [Abstract][Full Text] [Related]
2. Connect MM Registry: The Importance of Establishing Baseline Disease Characteristics.
Rifkin RM; Abonour R; Terebelo H; Shah JJ; Gasparetto C; Hardin J; Srinivasan S; Ricafort R; Nagarwala Y; Durie BG
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):368-76. PubMed ID: 25617035
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and survival of 338 multiple myeloma patients treated with hematopoietic stem cell transplantation or conventional chemotherapy.
Pérez R; Durán MS; Mayans J; Soler A; Castillo I; Jurado M; Ribas P; Menchaca Echevarria MC; Hernandez MT; Lopez Garcia-Carreño MD; Echeveste Gutierrez A; Bailen Garcia A; Lopez S; Baquero J; Ramirez G
Eur J Haematol; 2016 Apr; 96(4):417-24. PubMed ID: 26190662
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting outcome of patients with multiple myeloma.
Basit A; Siddiqui N; Hameed A; Muzaffar N; Athar S
J Ayub Med Coll Abbottabad; 2014; 26(3):376-9. PubMed ID: 25671952
[TBL] [Abstract][Full Text] [Related]
5. Review of 1027 patients with newly diagnosed multiple myeloma.
Kyle RA; Gertz MA; Witzig TE; Lust JA; Lacy MQ; Dispenzieri A; Fonseca R; Rajkumar SV; Offord JR; Larson DR; Plevak ME; Therneau TM; Greipp PR
Mayo Clin Proc; 2003 Jan; 78(1):21-33. PubMed ID: 12528874
[TBL] [Abstract][Full Text] [Related]
6. Frequency of hypercalcemia in patients of multiple myeloma in Karachi.
Mansoor S; Siddiqui I; Adil S; Kakapeto GN; Fatmi Z
J Coll Physicians Surg Pak; 2005 Jul; 15(7):409-12. PubMed ID: 16197869
[TBL] [Abstract][Full Text] [Related]
7. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
D'Anastasi M; Notohamiprodjo M; Schmidt GP; Dürr HR; Reiser MF; Baur-Melnyk A
AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of beta-catenin in multiple myeloma].
Li J; Zhang DB; Luo SK; Zhao Y; Huang BH; Gu JL
Ai Zheng; 2007 Sep; 26(9):1010-4. PubMed ID: 17927863
[TBL] [Abstract][Full Text] [Related]
9. Rapid progression of anemia related to tumor-lysis syndrome associated with bortezomib treatment in myeloma patients.
Suzuki K; Terui Y; Nishimura N; Ueda K; Mishima Y; Sakajiri S; Yokoyama M; Aiba K; Hatake K
Jpn J Clin Oncol; 2014 May; 44(5):435-41. PubMed ID: 24664944
[TBL] [Abstract][Full Text] [Related]
10. Femoral and skull metastasis with hypercalcemia: occurrence with esophageal carcinoma without dysphagia.
Shewchuk SM; Meneses BO; Lerma LB; Shnider BI
Arch Intern Med; 1982 Nov; 142(12):2207-9. PubMed ID: 7138170
[TBL] [Abstract][Full Text] [Related]
11. Multiple-myeloma: review of 231 cases.
Advani SH; Soman CS; Talwalkar GV; Lyer YS; Bhatia HM
Indian J Cancer; 1978 Jun; 15(2):55-61. PubMed ID: 374240
[No Abstract] [Full Text] [Related]
12. Correlation of sera TNF-alpha with percentage of bone marrow plasma cells, LDH, beta2-microglobulin, and clinical stage in multiple myeloma.
Jurisić V; Colović M
Med Oncol; 2002; 19(3):133-9. PubMed ID: 12482123
[TBL] [Abstract][Full Text] [Related]
13. [Role of orthopedic surgery in the treatment of bone metastasis].
Debeyre J; Goutallier D; Del'epine G; Sterkers Y; Missenard G
Rev Rhum Mal Osteoartic; 1985 Mar; 52(3):161-9. PubMed ID: 4001807
[No Abstract] [Full Text] [Related]
14. The Effect of Suppressed Levels of Uninvolved Immunoglobulins on the Prognosis of Symptomatic Multiple Myeloma.
Sarı M; Sarı S; Nalçacı M
Turk J Haematol; 2017 Jun; 34(2):131-136. PubMed ID: 27795224
[TBL] [Abstract][Full Text] [Related]
15. Profile and survival of tongue cancer patients in "Dharmais" Cancer Hospital, Jakarta.
Sutandyo N; Ramli R; Sari L; Soeis DS
Asian Pac J Cancer Prev; 2014; 15(5):1971-5. PubMed ID: 24716920
[TBL] [Abstract][Full Text] [Related]
16. Presentation of multiple myeloma occurring in the humerus after strain: a case report.
Yilmaz E
Clin Rheumatol; 2021 Jan; 40(1):389-392. PubMed ID: 32613389
[TBL] [Abstract][Full Text] [Related]
17. Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.
Palumbo A; Bringhen S; Falco P; Cavallo F; Ambrosini MT; Avonto I; Gay F; Caravita T; Bruno B; Boccadoro M
Cancer; 2007 Aug; 110(4):824-9. PubMed ID: 17594696
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of hypercalcemia using mithramycin].
Saint-Hillier Y; Perol C; Dupond JL; Apffel F; Leconte des Floris RL
J Urol Nephrol (Paris); 1975; 81(4-5):326-34. PubMed ID: 125801
[No Abstract] [Full Text] [Related]
19. [A case of multiple myeloma with an aggressive course and multiorgan plasmocytic involvement].
Wyszecka-Polk I; Ciepłuch H; Izycka E; Hała-Burda K
Pol Arch Med Wewn; 1996 Nov; 96(5):479-83. PubMed ID: 9091859
[TBL] [Abstract][Full Text] [Related]
20. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
